Notices
Notice No20210129-32Notice Date29 Jan 2021
CategoryCorporate ActionsSegmentEquity
SubjectScheme of Arrangement (Demerger) of Jubilant Life Sciences Limited (Scrip Code 530019)
Content

 

Trading Members of the Exchange are hereby informed that, pursuant to the Scheme of Arrangement (for Demerger) approved by the Hon’ble National Company Law Tribunal, Allahabad Bench (NCLT), Jubilant Life Sciences Limited has fixed the Record Date for the purpose of determining entitlement of the shareholders of the Company, as per details given below: 

COMPANY NAME

CODE

RECORD DATE

PURPOSE

EX-ENTITLEMENT  FROM

DATE &

SETT. NO.

Jubilant Life Sciences Limited

 (530019)

05/02/2021

 

 

As per Composite Scheme of Arrangement sanctioned by the Hon’ble National Company Law Tribunal, Allahabad Bench (NCLT), between, HSB Corporate Consultants  Private Limited (‘Transferor Company 1’), Jubilant Stock Holding Private Limited (‘Transferor Company 2’), SSB Consultants & Management Services Private Limited (‘Transferor Company 3’), JCPL Life Science Ventures and Holdings Private Limited (‘Transferor Company 4’), JSPL Life Science Services and Holdings Private Limited (‘Transferor Company 5’) [collectively, the ‘Transferor Companies’], Jubilant Life Sciences Limited (‘Demerged Company/ Transferee Company’) and Jubilant Ingrevia Limited (‘Resulting Company’ - name of Jubilant LSI Limited changed to Jubilant Ingrevia Limited) and their respective shareholders and creditors  -

Upon the coming into effect of the aforesaid Scheme and in consideration of the transfer of the Life  Science Ingredients Undertaking of Jubilant Life Sciences Limited into Jubilant Ingrevia Limited;

Jubilant Ingrevia Limited shall issue and allot Equity Shares to the shareholders of Jubilant Life Sciences Limited. Limited in the following proportion:

“1 fully paid up equity share of Re. 1/- each fully paid up of Jubilant Ingrevia Limited shall be issued and allotted for every fully paid up equity share of Re. 1/- each fully paid up held in Jubilant Life Sciences Limited.”

04/02/2021

DR-214/2020-2021

 

Note:

Pursuant to SEBI Circular No. SEBI/Cir/ISD/1/2010 dated November 2, 2010, Trading members are hereby informed that the trading in the equity shares of the aforesaid company shall be transferred from ‘A’ group to ‘T’ group w.e.f. February 04, 2021 and pursuant to SEBI Circular No. CIR/MRD/DP/01/2012 dated January 20, 2012; the aforesaid scrip shall be a part of Call Auction in Pre-open Session on February 04, 2021.

Subject to compliance with requisite formalities, the shares of Resulting company i.e. Jubilant Ingrevia Limited will be listed on BSE Limited.

 

 

 

Mangesh Tayde

Assistant General Manager –Listing Operations (CRD)

 

January 29, 2021